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Summary
Dietary factors may influence the risk for breast cancer and also the prognosis following diagnosis and treatment.
The aim of this study was to assess whether self-reported prediagnosis diet or other patient factors associated with
breast cancer incidence were predictive of recurrence and survival. Patients(n = 149) diagnosed with primary
breast cancer between 1989 and 1991 were followed for five or more years. Total energy (hazard ratio(HR) = 1.58,
95%, confidence interval(CI) = 1.05, 2.38) as well as total(HR = 1.46, 95% CI= 1.05, 2.01), saturated(HR =
1.79, 95% CI= 1.05, 3.04), and monounsaturated(HR = 1.65, 95% CI= 1.09, 2.49) fat intakes were associated
with increased risk, and energy-adjusted bread and cereal consumption(HR = 0.55, 95% CI = 0.33, 0.93) with
decreased risk of recurrence. Both total energy(HR = 1.58, 95% CI = 1.03, 2.43) and polyunsaturated fat
(HR = 1.84, 95% CI = 1.09, 3.13) intakes were associated with an increased risk of death. All associations
between dietary fat and recurrence and survival attenuated following energy adjustment. Oral contraceptive use
(HR = 1.28, 95% CI = 1.03, 1.60), lymph node positive status(HR = 2.36, 95% CI = 1.01, 5.49), and tumor
stage(HR = 2.22, 95% CI = 1.02, 4.81) were associated with increased risk of recurrence. Tumor stage(HR =
4.96, 95% CI = 1.86, 13.23), lymph node positive status(HR = 3.31, 95% CI = 1.38, 7.95), and estrogen
receptor negative status(HR = 2.46, 95% CI = 1.02, 5.94) were associated with increased risk, and arm muscle
circumference(HR = 0.27, 95% CI = 0.09, 0.86) and mammographic utilization(HR = 0.77, 95% CI =
0.61, 0.98) with decreased risk of death. Higher levels of energy, fat intakes, and selected patient characteristics
(particularly disease stage and anthropometric indicators of adiposity) appear to increase risk of recurrence and/or
shortened survival following the diagnosis of breast cancer.
Introduction
Ecological and analytical epidemiologic investigations
and laboratory studies have suggested that dietary fac-
tors may influence the genesis and incidence of breast
cancer. More recently, the question has been raised
whether diet or nutritional factors, such as body weight,
may continue to influence the natural history of this dis-
ease after diagnosis and treatment, thereby modifying
risks of recurrence and death.
Several studies have associated decreased survival
with prediagnosis fat intake, adjusted [1–3] or unad-
justed [4–6] for energy intake, whereas others [7–9]
failed to detect any association with dietary fat. Some
of these studies [1–3] found a harmful effect of fat in-
take, independent of energy, whereas others, in which
fat estimates were not energy-adjusted, were unable to
disentangle the effects of these closely-related factors.
Other, but not all, studies have also found protective
effects of intake of vegetables and fruits and associated
micronutrients, vitamin C and carotenoids [1, 3, 10].
Obesity may decrease survival [4, 9, 11–15], although
it is not known whether this reflects excess intake
of energy and fat or influences risk for independent
reasons.
The purpose of this study was to examine the ef-
fect on prognosis of both dietary intakes and other
patient factors, such as reproductive events, body mass,
and tumor characteristics, considering the endpoint of
disease recurrence in addition to survival, in a group
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of women with primary breast cancer who had been
identified and examined upon diagnosis of the disease.
We also examined whether the effects of dietary fac-
tors varied according to menstrual status, body mass,
and disease stage, which are critical variables with the
potential to confound or modify diet–disease outcome
relationships. This study also builds on an earlier study
[16], in which we explored relationships between diet
and prognostic tumor characteristics, by examining
whether dietary factors are related to rates of recurrence
and survival of treated patients.
Patients and methods
Patients
Subjects consisted of 149 primary breast cancer pa-
tients who had been seen for the first time during an
18-month period beginning in August, 1989, at the
Medical Center, University of Michigan. A patient
was excluded if (1) the diagnosis of breast cancer was
not biopsy-confirmed, (2) more than one month had
elapsed since her primary surgery was performed, (3)
the diagnosis at examination was of recurrent breast
cancer, (4) the dietary questionnaire was rendered un-
usable by numerous omissions, or (5) the patient was
unable to be interviewed for the study. Procedures
for this study were approved by the Institutional Re-
view Board of the School of Medicine, University of
Michigan.
Collection of dietary and other patient data
Study data were obtained early in the course of the
patient’s initial care. An interview was conducted with
each suspected or newly diagnosed breast cancer pa-
tient as close to the time of her breast cancer diagnosis
as possible (usually her initial clinic visit or, failing
that, the first post-operative visit). At the time of
this interview, dietary and anthropometric assessments
were performed, and the patient was queried about
her menstrual history and use of oral contraceptives
(OC) and hormone replacement therapy (HRT). She
was also asked to complete a questionnaire regarding
demographic background and reproductive history.
Anthropometric measurements, including height,
weight, triceps skinfold thickness (TSF), and midarm
circumference (MAC) were obtained by standard pro-
cedures [17]. Calculated indices included body mass
index (BMI ) = weight(kg)/height(m2) and arm mus-
cle circumference (AMC)(cm) = MAC − π × TSF.
Body mass index was corrected for arm muscle circum-
ference(kg/m2/cm) = BMI/AMC [17], because sole
reliance on weight or BMI can lead to misclassification
of some individuals as obese. Dividing BMI by arm
muscle circumference (BMI/AMC) provides an index
of adiposity which may be more accurate than BMI
alone because muscularity is thus considered in the
evaluation of the effect of body mass. This approach
is analogous to and modeled on the nutrient density
method of energy adjustment [18–20].
Tumor characteristics, including stage, lymph node
status, and estrogen receptor (ER) levels and status,
were obtained by review of hospital medical records or,
when necessary, by contacting outside institutions for
information which was missing from medical records.
Staging was based on the American Joint Commission
on Cancer system [21]. Biopsy specimens obtained to
ascertain diagnosis, either at the University of Michi-
gan Hospital or outside hospitals, were used to stage the
primary tumor and were assayed by the Department of
Pathology Ligand Laboratory using the biochemical,
dextran-coated charcoal method to determine ER lev-
els. The cut-point used to dichotomize ER status as
positive or negative was 10 fmol receptor protein/mg
cytosol. When insufficient biopsy tissue was available
for this method, a determination of receptor status was
made using immunohistochemical staining. Lymph
node status was based on the pathological findings of
axillary node dissections performed at the time of pri-
mary surgery. The presence or absence of metastatic
disease was based on the findings of a metastatic
workup which included liver function tests and, when
appropriate, bone or computed tomography scans and
biopsy of suspicious lesions.
Dietary assessment
Nutrient intakes were examined using a National Can-
cer Institute food frequency questionnaire (FFQ) [22].
The FFQ was designed to assess a subject’s usual diet
and to provide information on a variety of nutrients,
foods, and food groups. Approximately 100 food items
were selected for inclusion in the questionnaire on the
basis of their estimated contributions to the intake of a
variety of nutrients, particularly fat and vitamin A, by
the US population. The FFQ was semi-quantified, so
that a standard portion size for each of the food items
was presented, and the subjects were asked to indicate
both the frequency of their consumption of the item
and whether their usual intake was larger, the same, or
smaller than an indicated standard amount.
The FFQ was administered at the time of a pa-
tient’s first clinic visit, with a focus on the typical
diet during the year prior to diagnosis. Each patient
was taught how to complete the form and was asked
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to complete representative items in the presence of
an interviewer. Completed FFQs were collected by
the interviewer and checked for completeness, accu-
racy, phase shifts, and unusual responses. Patients with
problematic FFQ responses were queried for correct
information and when necessary, entire questionnaires
were interviewer–administered.
Traditional analytic methods used to assess food
content involved quantifying the carotenoids believed
to be potential precursors of vitamin A, with results
tabulated as vitamin A values in international units
or retinol equivalents [23]. With the nutrient content
database and software employed in this study, vita-
min A intake was quantified as total vitamin A and its
two components, preformed vitamin A (retinol) and
‘carotene’ (assumed to reflect the major vitamin A
precursors). A more recently released database, with
figures derived from modern HPLC methods, permits
increased accuracy in the assessment of carotenoids in
the diet [24, 25]. However, the correlation between
the intakes based on the early estimates and the new
food composition values has been found to be very high
[26], so that use of these data in analysis is expected to
approximate the relative carotenoid intakes across the
range consumed within a target group.
Recurrence and mortality data collection
Access was granted to the database of the University
of Michigan Tumor Registry. The Registry tracks all
breast cancer patients who have been treated at the
University Hospital with annual updates of their re-
currence and survival status. Each of the breast cancer
patients who had completed a FFQ at diagnosis was
searched using this system, yielding 149 cases who, be-
cause they received their primary care at the University
Hospital, had been actively followed. In cases where
the patient had suffered a recurrence, the date of the
diagnosis was noted, along with the type of recurrence
(local, regional, or distant). Similarly, for patients who
died, the date of death, as well as whether the death
was breast-cancer related, was noted. All recurrences
(local, regional, or distant) were analyzed together, as
were all deaths (breast-cancer related and unrelated).
Analysis
All data were entered into a computer-based file and an-
alyzed using SPSS for Windows (version 6.1.4, 1996,
SPSS, Chicago, IL). Descriptive statistics (means,
standard deviations, minima, maxima, and frequency
distributions) were calculated for all study variables
and were examined to determine whether assump-
tions of normal distribution were met. Variables not
normally distributed were log-transformed to achieve
normality prior to analysis. Correlations among the
independent variables were examined using Pearson
product-moment correlations. A series of Cox propor-
tional hazards analyses [27] was then conducted to
model each study variable in relation to both recurrence
and survival within the population as a whole. Variable
increments used in the proportional hazards analyses
were selected on the basis of distribution of the data
collected. Dietary variables were examined both be-
fore and after adjusting for energy. Energy adjustment
was carried out using the nutrient density method [18].
Analyses by others [19, 20] indicate that this method
provides the greatest power to detect associations and
estimates of risk which are the most stable and closest
to the null.
In a second set of Cox proportional hazards analy-
ses, energy-adjusted dietary variables were then exam-
ined in relation to both recurrence and survival within
menstrual status (pre- vs. postmenopausal), BMI (≤
27.0 vs. > 27.0 kg/m2), and disease stage (Stages 0
and I vs. II–IV) strata. A BMI cut-point of 27.0 kg/m2
was selected because this is the level at which ad-
verse health effects from overweight are believed to
begin to occur [28]. Finally, a series of multivariate
Cox analyses were performed, using a stepwise se-
lection procedure, to arrive at the strongest dietary
(dietary variables only) and overall (both dietary and
non-dietary variables) models of both recurrence and
survival. For descriptive purposes, means± SD are
reported.
Results
Table 1 provides a description of the study population
in terms of their demographic, reproductive, anthro-
pometric, dietary, and disease-related characteristics.
Bivariate Pearson correlations between selected dietary
and patient variables revealed several significant asso-
ciations. Energy intake was strongly correlated with
other dietary variables, including total dietary fat(r =
0.90; P < 0.001), carotene(r = 0.38; P < 0.001),
and bread and cereals(r = 0.36; P < 0.001), but not
with BMI. Carotene intake was strongly correlated with
green and yellow vegetables(r = 0.84; P < 0.001)
and total dietary fat(r = 0.27; P < 0.001) intakes, but
not with intake of breads and cereals. BMI was strongly
correlated with weight(r = 0.95; P < 0.001), tri-
ceps skinfold thickness(r = 0.71; P < 0.001), and
arm muscle circumference(r = 0.56; P < 0.001).
244 GA Saxe et al.




Age (yr) 57.8 ± 13.4 26–95
Age at menarche (yr) 13.2 ± 3.1 10–16
Age at menopause (yr) 46.6 ± 7.6 25–59
Parity 2.7 ± 1.5 0–7
Age at first birth (yr) 24.7 ± 5.8 15–44
Number of children breastfed 0.9 ± 1.4 0–6
Body weight (kg) 70.0 ± 16.3 45.5–123.6
Height (cm) 160.8 ± 11.7 113.0–179.1
Body mass index (kg/m2) 26.7 ± 5.9 15.7–48.9
Arm muscle circumference (cm) 20.3 ± 3.4 2.1–29.2
Oral contraceptive use (mon) 24.4 ± 47.5 0–264
Hormone replacement use (mon) 22.9 ± 52.2 0–324
Number of mammograms in past 5 years 2.8 ± 3.9 0–14
B. Dietary variables
Total energy (kcal/d) 1671.4 ± 755.2 451.7–5067.9
Fat, energy (% of kcal) 32. ± 7.0 11.3–50.2
Protein, energy (% of kcal) 16.8 ± 2.9 10.2–25.6
Carbohydrate, energy (% of kcal) 49.1 ± 8.4 31.2–74.2
Total fat (g/d) 60.4 ± 30.4 10.7–184.7
Saturated fat (g/d) 22.0 ± 11.9 3.8–78.9
Monounsaturated fat (g/d) 22.0 ± 11.7 2.9–70.3
Polyunsaturated fat (g/d) 10.9 ± 6.2 1.3–32.2
Fiber (g/d) 15.5 ± 9.6 2.9–58.2
Vitamin C (mg/d) 161.2 ± 114.5 21.0–636.9
Carotene(mg/d) 3543.9 ± 3395.1 334.3–26778.9
Retinol(mg/d) 874.2 ± 747.7 80.0–5089.0
Fruit (servings/week) 16.7 ± 13.5 0.6–85.5
Green and yellow vegetables (servings/week) 4.1 ± 3.7 0.1–23.0
Bread and cereal (servings/week) 8.3 ± 10.4 0–98.0
Beef (servings/week) 1.7 ± 1.2 0–5.9
Butter and margarine (servings/week) 6.2 ± 6.5 0–49.0
Alcohol (drinks/week) 2.4 ± 4.7 0–21.0
C. Categorical variables
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However, triceps skinfold thickness and arm muscle
circumference were not correlated with each other.
Table 2 shows the risks of recurrence and death
for the patient sample in relation to each of the study
variables. Among non-dietary patient characteristics,
risk of recurrence was increased for OC use, node-
positive status, and advanced stage. For OC use, the
risk of recurrence increased 1.28-fold with a 95%
confidence interval(CI) = 1.03, 1.60 for each three
years of use. For node-positive (compared with node-
negative) status, there was a 2.36-fold increased risk
(95% CI = 1.01, 5.49). For the stage, the risk in-
creased 2.22 times(95% CI = 1.02, 4.81) for each
successive increase in level. Among predictors of over-
all survival, muscularity was protective. The hazard
ratio (HR), analogous to the relative risk derived from
a logistic regression model, was 0.27 for each addi-
tional 10 cm of arm muscle circumference(95% CI=
0.09, 0.86). For each 1 cm of arm muscle circumfer-
ence, the HR was 0.92 (95% CI = 0.82, 1.04) for
recurrence and 0.88(95% CI= 0.79, 0.99) for death.
ER-negative status was associated with an increased
risk of dying (HR = 2.46; 95% CI = 1.02, 5.94)
compared with ER-positive status. Node-positive (vs.
node-negative) status was a strong predictor of death
(HR = 3.31; 95% CI = 1.38, 7.95). Finally, tumor
stage was also strongly related to the risk of dying
(HR = 4.96; 95% CI = 1.86, 13.23). Neither age
nor menstrual status was found to be related to either
outcome measure.
Dietary factors were examined both before and
after adjusting for total energy. Total energy intake
was itself associated with a 1.58-fold increased risk
(95% CI = 1.05, 2.38) of recurrence for every ad-
ditional 4,184 kJ/day (1,000 kcal/day) in the diet. For
every additional 418 kJ/day (100 kcal/day) in the diet,
the HR was 1.05(95% CI= 1.00, 1.09) for recurrence.
Closely related to the energy effect was that of total
fat and fat subtypes, unadjusted for energy intake. For
example, saturated fat intake was associated with a
1.79-fold increase in the risk of recurrence for every
additional 20 g/day in the diet(95% CI= 1.05, 3.04).
Increased intakes of both saturated and polyunsaturated
fats were also associated with increased risk of death.
For polyunsaturated fat, this amounted to a 1.84-fold
increased risk for each additional 10 g/day in the diet
(95% CI= 1.09, 3.13). Total carotene and its principal
food source, dark green and deep yellow vegetables,
were associated with increased risks of recurrence. For
carotene, this amounted to a 1.19-fold increased risk for
each additional increment of 2,000mg/day in the diet
(95% CI= 1.06, 1.34). However, neither carotene nor
green/yellow vegetables showed any relationship with
the risk of death. After adjusting for total energy intake,
all of the above dietary relationships disappeared, and
in the process, a protective effect of breads and cereals
(HR = 0.55; 95% CI= 0.33, 0.93 for each increment
of seven weekly servings) on risk of recurrence was
revealed.
Table 3 shows the stratum-specific risks, by men-
strual status, of recurrence and death in relation to
total energy as well as to the other dietary variables
after energy-adjustment. The only statistically signif-
icant finding in this analysis was the protective effect
of bread and cereal on recurrence in postmenopausal
subjects(HR = 0.32; 95% CI = 0.14, 0.71). Table 4
shows the stratum-specific risks, this time by BMI, of
recurrence and death in relation to total energy and
energy-adjusted dietary variables. In subjects in whom
BMI was ≤ 27.0 kg/m2, energy intake was associated
with a 1.55-fold increased risk of recurrence for each
additional 4,184 kJ/day (1,000 kcal/day)(95% CI =
1.02, 2.36), or a 1.04-fold increased risk for each addi-
tional 418 kJ/day (100 kcal/day) in the diet(95% CI=
1.00, 1.09). Among those with BMI> 27.0 kg/m2,
monounsaturated fat intake(HR = 10.70 for each
additional 15 g/day of intake; 95% CI= 1.15, 99.19)
was found to be a strong predictor of early recurrence.
Once again, however, no variable was associated with
increased risk of death in either stratum.
Stratum-specific risks of recurrence and death in
relation to total energy and energy-adjusted dietary
variables were also examined by tumor stage (data
not shown). In subjects with early stage (in situ
or Stage I) disease, the risk of recurrence was el-
evated in patients with higher intakes of carotene
(HR = 1.42; 95% CI = 1.11, 1.81) or its principal
food source, dark green and deep yellow vegetables
(HR = 1.46; 95% CI = 1.01, 2.13). In those with
later stage illness (Stages II–IV), monounsaturated fat
(HR = 6.87; 95% CI = 1.56, 30.35) was associ-
ated with an increased risk of recurrence, while fiber
(HR = 0.29; 95% CI = 0.09, 0.89 for each 10 g/day
increment) afforded protection. In subjects with later
stage breast cancer, the risk of death was also ele-
vated with increased total energy consumption(HR =
1.57 for each additional 4,184 kJ/day (1,000 kcal/day);
95% CI = 1.07, 2.30; HR = 1.05 for each additional
418 kJ/day (100 kcal/day); 95% CI= 1.01, 1.09).
Finally, Table 5 shows the strongest dietary and
overall multivariate models of recurrence and death
in the population as a whole. First, for the endpoint
of recurrence, a model comprised only of dietary
terms showed an increased risk for energy(HR =
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Table 2. Cox regression of breast cancer recurrence and death as predicted by patient characteristics and dietary factorsa
Recurrence(n = 28) Death(n = 26)
Hazard 95% confidence Hazard 95% confidence
ratio interval ratio interval
A. Patient characteristics and level
Age (per 10 years) 0.87 0.65, 1.17 1.24 0.93, 1.65
Menstrual status (pre- vs. postmenopausal) 0.99 0.46, 2.15 2.18 0.82, 5.80
Age at menarche (per year) 0.78 0.58, 1.05 0.93 0.73, 1.20
Age at menopause (per 5 years) 1.02 0.75, 1.39 1.03 0.76, 1.39
Parity (per live birth) 1.15 0.89, 1.48 1.16 0.88, 1.53
Age at first birth (per 5 years) 0.85 0.60, 1.20 0.93 0.64, 1.35
Number of children breastfed (per child) 0.50 0.05, 5.01 2.80 0.30, 25.90
Weight (per 10 kg) 0.85 0.66, 1.08 0.96 0.76, 1.21
Body mass index(> 27.0 vs. ≤ 27.0 kg/m2) 0.62 0.27, 1.41 0.74 0.32, 1.71
Arm muscle circumference (per 10 cm) 0.44 0.14, 1.45 0.27 0.09, 0.86
Oral contraceptives (per 3 years of use) 1.28 1.03, 1.60 1.10 0.84, 1.45
Hormone replacement (per year of use) 0.98 0.35, 2.73 0.78 0.28, 2.19
Mammograms (per mammogram) 1.06 0.97, 1.15 0.77 0.61, 0.98
Estrogen receptor status (negative vs. positive) 1.45 0.55, 3.81 2.46 1.02, 5.94
Lymph node status (positive vs. negative) 2.36 1.01, 5.49 3.31 1.38, 7.95
Stage (0, I vs. II–IV) 2.22 1.02, 4.81 4.96 1.86, 13.23
B. Dietary variable and level (unadjusted for energy):
Energy (per 1000 kcal/d) 1.58 1.05, 2.38 1.33 0.86, 2.04
Total fat (per 30 g/d) 1.46 1.05, 2.01 1.38 0.99, 1.91
Saturated fat (per 20 g/d) 1.79 1.05, 3.04 1.72 1.00, 2.96
Monounsaturated fat (per 15 g/d) 1.65 1.09, 2.49 1.50 0.98, 2.27
Polyunsaturated fat (per 10 g/d) 1.66 0.98, 2.80 1.84 1.09 3.13
Fiber (per 10 g/d) 1.28 0.92, 1.77 1.17 0.83, 1.66
Vitamin C (per 100 mg/d) 1.31 0.99, 1.74 1.07 0.77, 1.48
Carotene (per 2000mg/d) 1.19 1.06, 1.34 1.04 0.85, 1.27
Retinol (per 500mg/d) 1.07 0.85, 1.33 0.98 0.74, 1.30
Fruit (per 14 servings/week) 1.22 0.85, 1.75 1.21 0.86, 1.72
Green and yellow vegetables (per 3 servings/week) 1.30 1.05, 1.59 1.00 0.74, 1.37
Bread and cereal (per 7 servings/week) 0.73 0.46, 1.15 0.90 0.64, 1.27
Beef (per 1.5 servings/week) 1.04 0.67, 1.61 1.14 0.73, 1.80
Butter and margarine (per 5 servings/week) 1.04 0.81, 1.35 1.11 0.88, 1.40
Alcohol (per 2 drinks/week) 0.71 0.32, 1.57 1.09 0.81, 1.46
C. Dietary variable and level (adjusted for energy):
Fat (per 10% of energy) 1.42 0.82, 2.46 1.27 0.71, 2.27
Protein (per 5% of energy) 0.67 0.39, 1.51 0.71 0.34, 1.47
Carbohydrate (per 10% of energy) 0.98 0.63, 1.52 1.03 0.64, 1.65
Total fat (per 30 g/d) 1.85 0.71, 4.78 1.51 0.55, 4.14
Saturated fat (per 20 g/d) 1.89 0.47, 7.59 1.45 0.32, 6.62
Monounsaturated fat (per 15 g/d) 2.33 0.76, 7.11 1.77 0.53, 5.87
Polyunsaturated fat (per 10 g/d) 1.84 0.70, 4.84 2.21 0.81, 5.98
Fiber (per 10 g/d) 0.92 0.48, 1.76 1.06 0.53, 2.11
Vitamin C (per 100 mg/d) 1.03 0.69, 1.54 0.92 0.57, 1.47
Carotene (per 2000mg/d) 0.91 0.69, 1.19 0.91 0.69, 1.20
Retinol (per 500mg/d) 0.86 0.55, 1.37 0.84 0.51, 1.39
Fruit (per 14 servings/week) 0.96 0.63, 1.45 1.06 0.69, 1.63
Green and yellow vegetables (per 3 servings/week) 1.17 0.90, 1.52 0.97 0.70, 1.35
Bread and cereal (per 7 servings/week) 0.55 0.33, 0.93 0.87 0.58, 1.29
Beef (per 1.5 servings/week) 0.89 0.57, 1.39 0.95 0.62, 1.48
Butter and margarine (per 5 servings/week) 1.04 0.81, 1.34 1.11 0.88, 1.40
Alcohol (per 2 drinks/week) 0.82 0.54, 1.25 1.02 0.82, 1.27
a Each row represents a pair of separate Cox regression models, one for recurrence and one for death.
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Table 3. Cox regression of energy-adjusted dietary predictors of breast cancer recurrence and death, stratified
by menstrual statusa
Dietary factor and level Recurrence Death
Hazard 95% confidence Hazard 95% confidence
ratio interval ratio interval
A. Premenopausal: (n = 10/51) (n = 5/51)
Energy (per 1000 kcal) 1.82 0.59, 5.65 1.11 0.23, 5.45
Fat (per 10% of energy) 1.00 0.38, 2.62 1.65 0.35, 7.68
Protein (per 5% of energy) 0.82 0.26, 2.55 0.56 0.11, 2.88
Carbohydrate (per 10% of energy) 1.24 0.58, 2.65 1.18 0.39, 3.60
Total fat (per 30 g/d) 1.00 0.19, 5.34 2.40 0.17, 4.75
Saturated fat (per 20 g/d) 0.35 0.02, 5.80 1.27 0.03, 60.62
Monounsaturated fat (per 15 g/d) 0.88 0.10, 7.64 3.94 0.12, 127.87
Polyunsaturated fat (per 10 g/d) 2.68 0.65, 11.10 5.45 0.79, 37.58
Fiber (per 10 g/d) 1.07 0.34, 3.33 0.42 0.06, 3.04
Vitamin C (per 100 mg/d) 0.96 0.46, 2.01 0.49 0.11, 2.14
Carotene (per 2000mg/d) 1.12 0.87, 1.44 0.56 0.14, 2.21
Retinol (per 500mg/d) 1.32 0.41, 4.25 2.43 0.47, 12.50
Fruit (per 14 servings/week) 0.56 0.21, 1.49 0.17 0.01, 1.86
Green and yellow vegetables 1.38 0.94, 2.03 0.96 0.45, 2.02
(per 3 servings/week)
Bread and cereal (per 7 servings/week) 1.09 0.55, 2.13 1.19 0.48, 2.94
Beef (per 1.5 servings/week) 0.57 0.20, 1.59 0.54 0.12, 2.34
Butter and margarine (per 5 servings/week) 0.73 0.35, 1.52 0.73 0.35, 1.52
Alcohol (per 2 drinks/week) 0.41 0.01, 16.35 0.41 0.01, 16.35
B. Postmenopausal: (n = 18/98) (n = 21/98)
Energy (per 1000 kcal) 1.56 0.99, 2.46 1.26 0.81, 1.97
Fat (per 10% of energy) 1.05 0.98, 1.13 1.03 0.96, 1.09
Protein (per 5% of energy) 0.94 0.79, 1.12 0.93 0.79, 1.10
Carbohydrate (per 10% of energy) 0.99 0.93, 1.04 1.00 0.95, 1.05
Total fat (per 30 g/d) 2.46 0.79, 7.66 1.55 0.53, 4.51
Saturated fat (per 20 g/d) 3.54 0.73, 7.26 1.77 0.36, 8.65
Monounsaturated fat (per 15 g/d) 3.27 0.91, 11.69 1.63 0.47, 5.67
Polyunsaturated fat (per 10 g/d) 1.36 0.36, 5.15 1.86 0.55, 6.24
Fiber (per 10 g/d) 0.84 0.38, 1.88 1.14 0.55, 2.36
Vitamin C (per 100 mg/d) 1.06 0.66, 1.70 0.97 0.59, 1.59
Carotene (per 2000mg/d) 1.25 0.92, 1.69 1.12 0.80, 1.58
Retinol (per 500mg/d) 0.78 0.45, 1.36 0.65 0.36, 1.18
Fruit (per 14 servings/week) 1.16 0.73, 1.84 1.23 0.79, 1.91
Green and yellow vegetables 1.04 0.72, 1.50 0.95 0.65, 1.39
(per 3 servings/week)
Bread and cereal (per 7 servings/week) 0.32 0.14, 0.71 0.76 0.48, 1.22
Beef (per 1.5 servings/week) 1.11 0.63, 1.93 1.15 0.68, 1.94
Butter and margarine (per 5 servings/week) 1.19 0.88, 1.61 1.11 0.82, 1.50
Alcohol (per 2 drinks/week) 0.88 0.61, 1.27 1.07 0.88, 1.30
a Each row represents a pair of separate Cox regression models, one for recurrence and one for death.
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Table 4. Cox regression of energy-adjusted dietary predictors of breast cancer recurrence and death, stratified
by body mass indexa
Dietary factor and level Recurrence Death
Hazard 95% confidence Hazard 95% confidence
ratio interval ratio interval
A. Body mass index≤ 27.0 kg/m2 (n = 20/92) (n = 18/92)
Energy (per 1000 kcal) 1.55 1.02, 2.36 1.43 0.93, 2.17
Fat (per 10% of energy) 1.28 0.67, 2.43 1.57 0.75, 3.28
Protein (per 5% of energy) 0.76 0.36, 1.59 0.57 0.25, 1.31
Carbohydrate (per 10% of energy) 1.05 0.64, 1.73 1.08 0.61, 1.88
Total fat (per 30 g/d) 1.52 0.51, 4.53 2.15 0.61, 7.54
Saturated fat (per 20 g/d) 1.55 0.28, 8.62 3.73 0.52, 26.78
Monounsaturated fat (per 15 g/d) 1.52 0.42, 5.55 2.50 0.58, 10.83
Polyunsaturated fat (per 10 g/d) 1.75 0.52, 5.95 2.60 0.72, 9.36
Fiber (per 10 g/d) 1.23 0.56, 2.70 1.20 0.50, 2.90
Vitamin C (per 100 mg/d) 1.19 0.77, 1.82 0.89 0.51, 1.58
Carotene (per 2000mg/d) 1.23 0.99, 1.51 0.99 0.71, 1.40
Retinol (per 500mg/d) 0.94 0.53, 1.66 0.82 0.41, 1.65
Fruit (per 14 servings/week) 1.00 0.62, 1.62 1.03 0.60, 1.75
Green and yellow vegetables 1.17 0.89, 1.54 0.94 0.65, 1.37
(per 3 servings/week)
Bread and cereal (per 7 servings/week) 0.70 0.38, 1.17 0.94 0.59 1.49
Beef (per 1.5 servings/week) 0.55 0.28, 1.08 0.79 0.43, 1.44
Butter and margarine (per 5 servings/week) 1.05 0.75, 1.45 1.03 0.73, 1.46
Alcohol (per 2 drinks/week) 0.90 0.64, 1.28 0.83 0.39, 1.79
B. Body mass index> 27.0 kg/m2 (n = 8/57) (n = 8/57)
Energy (per 1000 kcal) 1.46 0.43, 5.00 0.71 0.22, 2.29
Fat (per 10% of energy) 2.38 0.77, 7.37 0.95 0.35, 2.59
Protein (per 5% of energy) 0.73 0.16, 3.27 1.37 0.29, 6.59
Carbohydrate (per 10% of energy) 0.75 0.30, 1.88 0.89 0.37, 2.17
Total fat (per 30 g/d) 4.41 0.65, 30.00 0.92 0.17, 5.06
Saturated fat (per 20 g/d) 4.43 0.42, 46.40 0.38 0.03, 5.21
Monounsaturated fat (per 15 g/d) 10.70 1.15, 99.19 1.04 0.13, 8.68
Polyunsaturated fat (per 10 g/d) 2.50 0.51, 12.28 2.10 0.41, 10.70
Fiber (per 10 g/d) 0.52 0.14, 2.00 0.92 0.29, 2.92
Vitamin C (per 100 mg/d) 0.66 0.26, 1.68 0.97 0.44, 2.13
Carotene (per 2000mg/d) 1.02 0.65, 1.61 1.04 0.68, 1.60
Retinol (per 500mg/d) 0.82 0.38, 1.78 0.91 0.43, 1.89
Fruit (per 14 servings/week) 0.87 0.38, 1.98 1.12 0.54, 2.34
Green and yellow vegetables 1.01 0.50, 2.03 1.03 0.51, 2.05
(per 3 servings/week)
Bread and cereal (per 7 servings/week) 0.29 0.08, 1.05 0.73 0.34, 1.59
Beef (per 1.5 servings/week) 1.77 0.97, 3.21 1.36 0.67, 2.75
Butter and margarine (per 5 servings/week) 1.15 0.65, 2.05 1.34 0.76, 2.36
Alcohol (per 2 drinks/week) 0.35 0.02, 8.00 1.16 0.84, 1.62
a Each row represents a pair of separate Cox regression models, one for recurrence and one for death.
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Table 5. Strongest dietary and overall multivariate Cox regression models of breast cancer
recurrence and death
Significance Hazard 95% confidence
(P value) ratio interval
Recurrence – dietary variables:
Energy (per 1,000 kcal) 0.0236 1.64 1.07, 2.53
Breads and cereals (per 7 servings/week)a 0.0266 0.56 0.33, 0.93
Recurrence – all variables:
Energy (per 1,000 kcal) 0.0063 1.84 1.19, 2.86
Oral contraceptives (per 3 years of use) 0.0143 1.34 1.06, 1.69
Tumor stage (per each stage increase) 0.0508 1.48 1.00, 2.20
Breads and cereals (per 7 servings/week)a 0.0728 0.63 0.38, 1.04
Death – dietary variables:
Polyunsaturated fat (per 10 g/d)b 0.0234 1.84 1.09, 3.13
Death – all variables:
Tumor stage (per each stage increase) 0.0000 2.88 1.82, 4.57
BMI/AMC c (per kg/m2/cm) 0.0027 1.64 1.19, 2.26
Energy (per 1,000 kcal) 0.0368 1.58 1.03, 2.43
aEnergy-adjusted.
bNon-energy-adjusted.
cBMI = body mass index, weight(kg)/height(m2); AMC = Arm muscle circumference (cm).
1.64; 95% CI = 1.07, 2.53) and a decreased risk for
bread and cereal(HR = 0.56; 95% CI = 0.33, 0.93).
Total dietary fat and fat subtypes also contributed to sig-
nificant predictive models in the absence of adjustment
for total energy, but attenuated in effect or dropped out
altogether from the multivariate models when the effect
of energy was considered. When non-dietary variables
were also introduced into multivariate models of recur-
rence, two variables, OC use(HR = 1.34; 95% CI =
1.06, 1.69 for every three years of use) and tumor stage
(HR = 1.48; 95% CI= 1.00, 2.20 for each increment
in stage) were found to add to the predictive power and
provide the most robust model.
In developing a model for predicting the outcome of
death, the strongest dietary model consisted of only one
statistically significant term: polyunsaturated fat intake
unadjusted for energy intake(HR = 1.84; 95% CI =
1.09, 3.13). Other fat subtypes, also unadjusted for en-
ergy, approached or achieved significance in bivariate
models, but attenuated or dropped out of multivari-
ate Cox regression models. When non-dietary patient
characteristics were also introduced into a multivariate
model of risk of death, energy (rather than fat or bread
and cereal) intake was found to be the strongest dietary
variable and to contribute to the most robust model.
In addition to energy intake, two non-dietary variables
were found to be very strong predictors of death: tumor
stage and BMI adjusted for arm muscle circumference.
Tumor stage was indeed a powerful predictor, with a
2.88-fold increase(95% CI = 1.82, 4.57) in the risk
of death for each one stage increase. BMI, on its own,
failed to predict outcome in any setting. However, when
adjusted for arm muscle circumference, BMI was a
powerful predictor of risk of death with an attendant
1.64-fold increased risk(95% CI = 1.19, 2.26) for
each incremental kg/m2/cm.
Discussion
We found several dietary and non-dietary factors to
be associated with modification of risks of breast can-
cer recurrence and death following diagnosis. Higher
levels of energy and fat intakes, OC use, ER-negative
status, and advanced disease stage appear to be associ-
ated with an adverse effect on breast cancer outcome,
whereas greater muscularity, increased intake of breads
and cereals, and more frequent mammograms appear
to be protective.
In the present study, prior to energy-adjustment,
intakes of total fat, as well as of saturated and monoun-
saturated fat, were associated with increased risks of
recurrence, and polyunsaturated fat intake was associ-
ated with increased risk of death. Among earlier studies
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that examined the relationship of diet with breast can-
cer outcome, several found an association between
increased prediagnosis dietary fat intake and poorer
survival [1–6], whereas others [7–9] failed to detect
any relationship with fat intake. Other, but not all,
studies found protective effects of intake of vegetables
and fruits and their associated micronutrients, vitamin
C andb-carotene [1, 3, 10]. Several studies [4, 9, 11–
15] have also implicated obesity in decreased survival,
principally among postmenopausal patients.
Energy intake, however, may have accounted for at
least part of the effect attributed to fat intake. A higher
level of energy intake has been firmly established in
animal models to be a potent mammary tumor promoter
[29]. When compared with restricted energy intake,ad
libitum intake has been shown to result in more tumors,
more rapid onset, enhanced tumor growth, and more
metastases [30]. It is conceivable that the tumorigenic
effects of energy intake also pertain to humans, and
therefore, it is not surprising that the adverse effects
of fat were attenuated or disappeared upon energy-
adjustment. In fact, energy intake is closely related to
intakes of many nutrients, particularly fat, and very
high correlations (identical to those observed in this
population) have been reported in numerous previous
studies [30, 31]. In the present study, energy intake was
found to be an important independent risk factor for
both recurrence and death, and the effects of energy in-
take may even have been underestimated. Overweight
women tend to under-report energy intake [32], thereby
confounding energy intake effects with the possibly
beneficial effects of leanness. Also, decreased reported
energy intake may have resulted from advanced disease
at diagnosis. Finally, in more physically fit subjects, in-
creased energy intake could have been associated with
a possibly beneficial increased expenditure. Therefore,
the adverse effects of energy intake may have been
spuriously underestimated.
Among other dietary relationships with outcome,
intake of breads and cereals was found to be protective
against recurrence in the present study. The beneficial
effect was particularly pronounced in postmenopausal
women(HR = 0.32; 95% CI= 0.14, 0.71). This pro-
tective effect may have occurred because these foods
are a rich source of fiber, a non-nutritive dietary compo-
nent which has been associated with lower circulating
estradiol concentrations, increased fecal estrogen, and
lower breast cancer incidence [33].
The unexpected association between carotene in-
take (when unadjusted for energy intake) and an in-
creased risk of recurrence is difficult to interpret on
the basis of results from previous studies. This associ-
ation disappeared upon energy adjustment, reflecting
carotene associations with intakes of energy and total
dietary fat. Nevertheless, this finding was surprising
because dietary (as opposed to supplemental) carotene
has generally tended to be protective in terms of the
incidence of breast and other cancers [34–36].
As expected, inherent tumor characteristics were
most prognostically important among the non-dietary
factors. Tumor stage was associated with recurrence
and was the strongest of all predictors of death. Sim-
ilarly, lymph node–positive status was also strongly
predictive of both endpoints. ER-negative status was
associated with death but was unrelated to disease
recurrence. Mammographic utilization (frequency of
mammograms during the five years prior to diagnosis),
because of its ability to detect the disease at an ear-
lier stage, was also associated with a decreased risk
of death. Although associated with breast cancer in-
cidence, reproductive factors (ages at menarche and
menopause, age at first birth, gravida and parity, and
breastfeeding) were unrelated to either endpoint.
Arm muscle circumference, a measure of lean body
mass, was strongly associated with a decreased risk of
death. This finding may have resulted from a beneficial
effect of exercise and physical activity and is consistent
with recent observations that breast cancer incidence is
reduced in individuals who are more physically active
[37–41]. However, it is also possible that it reflects
a loss of lean muscle mass by patients with advanced
disease. Nonetheless, the persistence of a protective ef-
fect of arm muscle circumference when controlling for
tumor stage suggests that physical activity may indeed
be beneficial. While no effects were noted for weight
or BMI, the correction of BMI for muscularity yielded
an index of adiposity that was directly associated with
death. This was a stronger effect than that of arm muscle
circumference in the opposite (protective) direction,
and second in strength only to that of disease stage.
A number of mechanisms have been suggested to
explain the relationship between excess energy intake,
increased adiposity, and the promotion of mammary
carcinogenesis, which has been observed in animal
model systems [29, 30] and is suggested by the results
of the present study. Most of these mechanisms relate
to the hormonal and metabolic factors that are associ-
ated with increased energy intake or obesity. Insulin,
secreted in response to meals to enable glucose clear-
ance and energy metabolism, and insulin-like growth
factors may have direct effect on the development and
promotion of breast cancer [42]. Substantial evidence
specifically implicates circulating estrogens as a key
factor in modulating breast carcinogenesis [43–45],
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and dietary and physical activity patterns may influence
risk for recurrence due to effects on estrogen production
and metabolism. Adipose tissue provides the site for
peripheral aromatization of androstenedione to estrone,
a mechanism that may be particularly important in the
promotion of postmenopausal breast cancer [46].
Finally, among the non-dietary factors, a history of
OC use was strongly predictive of recurrence. The ad-
verse effect of OC use was stronger in postmenopausal
than in premenopausal women, a finding that is bi-
ologically feasible because postmenopausal subjects
used OC in the distant past when the average estrogen
concentration of these formulations was higher. No
association between HRT and recurrence or death was
observed.
Our study had several important limitations. The
sample size may have limited the power to detect ef-
fects, particularly in stratified analyses. Similarly, the
relative dietary homogeneity (with respect to fat and
other nutrients) in this patient population may have
attenuated risk estimates, biasing results toward the
null. Therefore, even though significant relationships
between intakes of energy, fat, and other dietary vari-
ables and outcome were observed, it is possible that a
wider distribution of intakes or a greater sample size
would have amplified effects which were underesti-
mated or revealed those which were undetected. Also,
only prediagnosis diet, reflecting the year prior to the
examination and diagnosis, was assessed. It is possible
that the subjects may have changed their diets after
diagnosis, either as a consequence of their disease and
its treatment or, possibly, in an attempt to reduce risk
for recurrence or death. It is also possible that in those
with advanced disease at the time of diagnosis, prediag-
nosis diet may have reflected taste or appetite changes
resulting from the breast cancer. Notably, these women
were not the target of dietary intervention efforts, and
the likelihood of many spontaneous and substantial
changes in well-established adult eating patterns seems
small. Etiologic factors associated with risk of breast
cancer are plausibly related to progression following
the diagnosis of breast cancer [3], and additionally,
prediagnosis dietary and activity patterns may even be
among the determinants of tissue characteristics that
influence prognosis [47].
Finally, the dietary data in the present study should
be interpreted cautiously. FFQs are imprecise methods
of dietary assessment. The potential bias toward the
null, or an overestimate of intake, may have obscured
relationships between the dietary variables and out-
come factors. Data from FFQs may be particularly
imprecise when micronutrient content data, such as
carotenoids, are examined [48]. Use of the recently-
released carotenoid database [25] in the dietary assess-
ment would have enhanced the examination of dietary
intakes of these compounds in this population. Nev-
ertheless, total energy, fat, and other macronutrient
intakes for this population were very close to values
reported for women of a similar mean age from national
surveys [49], providing confidence in the validity of
the FFQ and the dietary data with respect to intakes of
energy and macronutrients.
This study also had important strengths. First,
recurrence was assessed as an outcome variable in addi-
tion to death. Most previous studies that have addressed
the association between diet and breast cancer outcome
have not examined the endpoint of disease recurrence
[1, 3–6]. Although there is considerable overlap, risk
factors for each of these two events were not identi-
cal. A second strength of this study is that nutrient
estimates were energy-adjusted. Unfortunately, some
of the earlier studies [4–6] failed to energy-adjust and
were, therefore, unable to separate the effects of energy
intake from those of other nutrient intakes. Finally,
this study employed anthropometric assessments be-
yond weight, height, and BMI. This permitted a more
refined analysis of the effects of weight and BMI by
their relative adipose and muscle components [17], re-
vealing relationships which would have otherwise been
obscured.
In conclusion, we found that a combination of
factors, including high intakes of energy and/or fat,
obesity, and use of older formulations of OC may be
associated with a poor prognosis after a diagnosis of
breast cancer. Conversely, protection against breast
cancer recurrence and death may be afforded by regu-
lar exercise (to promote increased lean body mass), a
high intake of breads and cereals, and earlier detection
through regular mammograms. Future research will
aim to further refine these findings and to determine
whether they are valid and abiding.
Acknowledgements
Supported by a research grant from Blue Cross – Blue
Shield of Michigan. We thank the past and present
members of the University of Michigan Breast Care
Center who made this study possible, particularly Drs.
Jay Harness, Allen Lichter, Lynne Carpenter, Hal
Oberman, and David August. Special thanks also to Dr.
Fred Wright for his valuable biostatistical guidance, to
Dr. Jack McCue for his timely editorial assistance, and
to Ms. Gretchen Miela for her help in obtaining Tumor
Registry data.
252 GA Saxe et al.
References
1. Jain M, Miller AB, To T: Premorbid diet and the prognosis
of women with breast cancer. J Natl Cancer Inst 86: 1390–
1397, 1994
2. Holm LE, Nordevang E, Hjalmar ML, Lidbrink E, Callmer
E, Nilsson B: Treatment failure and dietary habits in women
with breast cancer. J Natl Cancer Inst 85: 32–36, 1993
3. Rohan TE, Hiller JE, McMichael AJ: Dietary factors and
survival from breast cancer. Nutr Cancer 20: 167–177, 1993
4. Zhang S, Folsom AR, Sellers IA, Kushi LH, Potter JD:
Better breast cancer survival for postmenopausal women
who are less overweight and eat less fat. The Iowa Women’s
Health Study. Cancer 76: 275–283, 1995
5. Nomura AMY, Le Marchand L, Kolonel LN, Hankin JH:
The effect of dietary fat on breast cancer survival among
Caucasian and Japanese women in Hawaii. Breast Cancer
Res Treat 18(suppl): 135–141, 1991
6. Gregorio DI, Emrich LJ, Graham S, Marshall JR, Nemoto
T: Dietary fat consumption and survival among women with
breast cancer. J Natl Cancer Inst 75: 37–41, 1985
7. Kyogoku S, Hirohata T, Nomura Y, Shigematsu T, Takeshita
S, Hirohata I: Diet and prognosis of breast cancer. Nutr
Cancer 17: 271–277, 1992
8. Ewertz M, Gillanders S, Meyer L, Zedeler K: Survival of
breast cancer patients in relation to factors which affect the
risk of developing breast cancer. Int J Cancer 49: 526–530,
1991
9. Newman SC, Miller AB, Howe GR: A study of the effect of
weight and dietary fat on breast cancer survival time. Am J
Epidemiol 123: 767–774, 1986
10. Ingram D: Diet and subsequent survival in women with
breast cancer. Br J Cancer 69: 592–595, 1994
11. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SWC, Buz-
dar AU: Obesity as an adverse prognostic factor for patients
receiving adjuvant chemotherapy for breast cancer. Ann
Intern Med 119: 18–25, 1993
12. Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW:
Obesity at diagnosis of breast cancer influences duration
of disease-free survival. Ann Intern Med 116: 26–32, 1992
13. Boyd NF, Campbell JE, Germanson T, Thomson DB,
Sutherland DJ, Meakin JW: Body weight and prognosis in
breast cancer. J Natl Cancer Inst 67: 785–789, 1981
14. Tartter PI, Papatestas AE, Ioannovich J, Mulvihill MN,
Lesnick G, Aufses AH: Cholesterol and obesity as prog-
nostic factors in breast cancer. Cancer 47: 2222–2227,
1981
15. Donegan WL, Hartz AJ, Rimm AA: The association of body
weight with recurrent cancer of the breast. Cancer 41: 1590–
1594, 1978
16. Rock CL, Saxe GA, Ruffin MT, August DA, Schottenfeld
D: Carotenoids, vitamin A, and estrogen receptor status in
breast cancer. Nutr Cancer 25: 81–96, 1996
17. Heymsfield SB, Tighe A, Wang ZM: Nutritional assessment
by anthropometric and biochemical methods. In: Shils M,
Olson JA, Shike M (eds) Modern Nutrition in Health and
Disease. Lea and Febiger, Philadelphia, 1994, pp 812–841
18. Willett W, Stampfer MJ: Total energy intake: implications
for epidemiologic analyses. Am J Epidemiol 124: 17– 27,
1986
19. Kushi LH, Potter JD, Bostick RM, Drinkard CR, Sellers
TA: Dietary fat and risk of breast cancer according to hor-
mone receptor status. Cancer Epidemiol Biomarkers Prev 4:
11–19, 1995
20. Brown CC, Kipnis V, Freedman LS, Hartman AM,
Schatzkin A: Energy-adjustment methods for nutritional
epidemiology: the effect of categorization. Am J Epidemiol
139: 323–338, 1994
21. Beahrs O, Henson D, Hutter R, Myers M (eds): Manual for
Staging of Cancer, 3rd edition. Lippincott, Philadelphia,
1988, pp 145–150
22. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon
J, Gardner L: A data-based approach to diet questionnaire
design and testing. Am J Epidemiol 124: 453–469, 1986
23. Beecher GR, Chachik F: Evaluation of vitamin A and
carotenoid data in food composition tables. J Natl Cancer
Inst 73: 1397–1404, 1981
24. Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza
E: Carotenoid content of fruits and vegetables: an evaluation
of analytic data. J Am Diet Assoc 93: 284–296, 1993
25. Chug-Ahuja JK, Holden JM, Forman MR, Mangels AR,
Beecher GR, Lanza E: The development and application of
a carotenoid database for fruits, vegetables, and selected
multicomponent foods. J Am Diet Assoc 93: 318–323,
1993
26. Hankin JH, Le Marchand L, Kolonel LN, Wilkens LR: As-
sessment of carotenoid intakes in humans. Ann NY Acad
Sci 691: 68–75, 1993
27. Cox DR: Regression models and life-tables. J R Stat Soc
34: 187–220, 1972
28. Manore M, Benardot D, Love P: Body measurements.
In: Benardot D (ed) Sports Nutrition. American Dietetic
Association, Chicago, 1992, pp 70–93
29. Klurfeld DM, Weber MM, Kritchevsky D: Inhibition of
chemically-induced mammary and colon tumor promotion
by calorie restriction in rats fed increased dietary fat. Cancer
Res 47: 2759–2762, 1987
30. Albanes D: Energy intake and cancer. In: Micozzi MS,
Moon TE (eds) Macronutrients: Investigating their Role in
Cancer. Marcel Dekker, New York, 1992, pp 205–229
31. Willett W, Stampfer MJ: Total energy intake: implications
for epidemiologic analyses. Am J Epidemiol 124: 17– 27,
1986
32. Lichtman SW, Pisarska K, Berman ER, Pestone M, Dowling
H, Offenbacher E, Heshka S, Mathews DE, Heymsfield SB:
Discrepancy between self-reported and actual caloric intake
and exercise in obese subjects. N Eng J Med 327: 1893–
1898, 1992
33. Lanza E, Shankar S, Trock B: Dietary fiber. In: Micozzi MS,
Moon TE (eds) Macronutrients: Investigating their Role in
Cancer. Marcel Dekker, New York, 1992, pp 293–319
34. Van Poppel G: Carotenoids and cancer: an update with em-
phasis on human intervention studies. Eur J Cancer 29A:
1335– 1344, 1993
35. Comstock GGW, Bush TL, Helzlsouer K: Serum retinol,
beta-carotene, vitamin E, and selenium as related to sub-
sequent cancer of specific sites. Am J Epidemiol 135:
115–121, 1992
36. Potischman N, McCulloch CE, Byers T, Nemoto T, Stubbe
N: Breast cancer and dietary and plasma concentrations of
carotenoids and vitamin A. Am J Clin Nutr 52: 909–915,
1990
37. Thune I, Brenn T, Lund E, Gaard M: Physical activity and
the risk of breast cancer. N Eng J Med 336: 1269–1275,
1997
38. Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM,
Ross RK: Risk factors forin situ breast cancer. Cancer
Epidemiol Biomarkers Prev 5: 961–965, 1996
Diet and risk for breast cancer recurrence and survival253
39. D’Avanzo B, Nanni O, La Vecchia C, Franceschi S, Negri
E, Giacosa A, Conti E, Montella M, Talamini R, Decarli A:
Physical activity and breast cancer risk. Cancer Epidemiol
Biomarkers Prev 5: 155–160, 1996
40. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J,
Ross RK: Physical exercise and reduced risk of breast cancer
in young women. J Natl Cancer Inst 86: 1403–1408, 1994
41. Frisch RE, Wyshak G, Albright NL, Albright TE, Schiff I,
Johns KP, Witski J, Shiang E, Koff E, Marguglio M: Lower
prevalence of breast cancer and cancers of the reproductive
system among former college athletes compared to non-
athletes. Br J Cancer 52: 885–891, 1985
42. Westley BR, May FED: Insulin-like growth factors: the
unrecognized oncogenes. Br J Cancer 72: 1065–1066, 1995
43. Key TJ, Pike MC: The role of oestrogens and progestagens
in the epidemiology and prevention of breast cancer. Eur J
Cancer Clin Oncol 24: 29–43, 1988
44. Pike MC, Spicer DV, Dahmoush T, Press MF: Estrogens,
progestogens, normal breast cell proliferation and breast
cancer risk. Epidemiol Rev 15: 17–35, 1993
45. Bernstein L, Ross RK: Endogenous hormones and breast
cancer risk. Epidemiol Rev 15: 48–65, 1993
46. Le Marchand L: Anthropometry, body composition, and
cancer. In: Micozzi MS, Moon TE (eds) Macronutrients:
Investigating their Role in Cancer. Marcel Dekker, New
York, 1992, pp 321–342
47. Russo J, Russo IH: Toward a physiologic approach to breast
cancer prevention. Cancer Epidemiol Biomarkers Prev 3:
353–364, 1994
48. Briefel RR, Flegal KM, Winn DM, Loria CM, Johnson CL,
Sempos CT: Assessing the nation’s diet: limitations of the
food frequency questionnaire. J Am Diet Assoc 92: 959–
962, 1992
49. Block G, Dresser CM, Hartman AM, Carroll MD: Nutrient
sources in the American diet: quantitative date from the
NHANES II Survey. II. Macronutrients and fats. Am J
Epidemiol 122: 27–40, 1985
Address for offprints and correspondence:Cheryl L. Rock, PhD,
RD, Cancer Prevention and Control Program, University of Cali-
fornia, San Diego, 9500 Gilman Drive, Dept. 0901, La Jolla, CA
92093–0901, USA;Tel: 619-822-1126;Fax: 619-822-1497
